GD2 targeting CAR T cells for neuroblastoma
Treatment of neuroblastoma is a significant clinical unmet need in paediatric oncology epitomised by high-risk disease in which relapse is common and outcomes for children with relapse or primary refractory disease are typically poor, with 4-year progression-free survival for relapse/refractory dise...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | EJC Paediatric Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X24000382 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|